Elysium Heath also announced Morgan Levine, Ph.D., of Yale School of Medicine has joined the company as head of bioinformatics to improve the testing methodology of Index, with the goal of making its application accurate and informative for individuals.
John Halamka, M.D., will oversee Mayo Clinic Platform as it carries out initial projects focused on home healthcare scheduling, patient data uploading, and supplying patient-specific treatment information based on Mayo Clinic data.
Promega’s MSI testing is designed to functionally measure the genomic accumulation of insertion or deletion (INDEL) errors caused by a deficient mismatch-repair system (dMMR) that occurs in certain types of solid tumors.
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
QFT-Plus is designed to offer streamlined laboratory automation for latent TB screening, supporting conversion from century-old tuberculin skin tests to fourth-generation blood-based QuantiFERON technology.
Researchers from the Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and nine other centers, presented interim results at the American Society of Clinical Oncology...
The volume of information that needs to be analyzed to make precision medicine a reality in cancer care is often beyond the realm of the human mind. That’s where artificial intelligence steps in
Investigators at the Dana-Farber Cancer Institute, in conjunction with researchers at the Broad Institute of MIT and Harvard, have discovered that a metabolic imbalance...
The researchers used a Cancer rainbow (Crainbow) modeling system for fluorescently barcoding somatic mutations to directly visualize the clonal expansion and spread of oncogenes.
The company will initially use the FDA-cleared, automated nCounter system which can simultaneously analyze RNA, DNA or protein targets in up to 800 genes, for uses in diopathic pulmonary fibrosis diagnosis and breast cancer diagnosis.